These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 24716528

  • 1. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K, Sansyzbay A, Kydyrbayev Z, Yespembetov B, Ryskeldinova S, Zinina N, Assanzhanova N, Sultankulova K, Sandybayev N, Khairullin B, Kuznetsova I, Ferko B, Egorov A.
    Virol J; 2014 Apr 10; 11():69. PubMed ID: 24716528
    [Abstract] [Full Text] [Related]

  • 2. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A.
    Vaccine; 2014 Apr 11; 32(18):2034-41. PubMed ID: 24598723
    [Abstract] [Full Text] [Related]

  • 3. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
    Tabynov K, Yespembetov B, Ryskeldinova S, Zinina N, Kydyrbayev Z, Kozhamkulov Y, Inkarbekov D, Sansyzbay A.
    Vaccine; 2016 Jan 20; 34(4):438-444. PubMed ID: 26709638
    [Abstract] [Full Text] [Related]

  • 4. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs.
    Bugybayeva D, Ryskeldinova S, Zinina N, Sarmykova M, Assanzhanova N, Kydyrbayev Z, Tabynov K.
    Biomed Res Int; 2020 Jan 20; 2020():1438928. PubMed ID: 33274194
    [Abstract] [Full Text] [Related]

  • 5. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
    Luo D, Ni B, Li P, Shi W, Zhang S, Han Y, Mao L, He Y, Wu Y, Wang X.
    Infect Immun; 2006 May 20; 74(5):2734-41. PubMed ID: 16622210
    [Abstract] [Full Text] [Related]

  • 6. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.
    Bugybayeva D, Kydyrbayev Z, Zinina N, Assanzhanova N, Yespembetov B, Kozhamkulov Y, Zakarya K, Ryskeldinova S, Tabynov K.
    Infect Dis Poverty; 2021 Feb 16; 10(1):13. PubMed ID: 33593447
    [Abstract] [Full Text] [Related]

  • 7. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S.
    Mol Immunol; 2015 Aug 16; 66(2):384-91. PubMed ID: 25968974
    [Abstract] [Full Text] [Related]

  • 8. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A, Yespembetov B, Ryskeldinova S, Zinina N, Sansyzbay A, Renukaradhya GJ, Petrovsky N, Tabynov K.
    PLoS One; 2017 Aug 16; 12(10):e0186484. PubMed ID: 29023541
    [Abstract] [Full Text] [Related]

  • 9. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers.
    Tabynov K, Yespembetov B, Sansyzbay A.
    Vaccine; 2014 Oct 14; 32(45):5889-92. PubMed ID: 25218295
    [Abstract] [Full Text] [Related]

  • 10. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.
    Pontes DS, Dorella FA, Ribeiro LA, Miyoshi A, Le Loir Y, Gruss A, Oliveira SC, Langella P, Azevedo V.
    J Drug Target; 2003 Oct 14; 11(8-10):489-93. PubMed ID: 15203917
    [Abstract] [Full Text] [Related]

  • 11. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
    Senevirathne A, Hewawaduge C, Lee JH.
    Vet Res; 2020 Jan 23; 51(1):6. PubMed ID: 31973749
    [Abstract] [Full Text] [Related]

  • 12. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S, Peddayelachagiri BV, Nagaraj S, Konduru B, Batra HV.
    Appl Microbiol Biotechnol; 2018 Oct 23; 102(20):8895-8907. PubMed ID: 30136204
    [Abstract] [Full Text] [Related]

  • 13. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response.
    Kurar E, Splitter GA.
    Vaccine; 1997 Dec 23; 15(17-18):1851-7. PubMed ID: 9413093
    [Abstract] [Full Text] [Related]

  • 14. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P, Surendran N, Seleem MN, Sriranganathan N, Schurig GG, Boyle SM.
    Vaccine; 2011 Apr 12; 29(17):3106-10. PubMed ID: 21376799
    [Abstract] [Full Text] [Related]

  • 15. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
    Pakzad I, Rezaee A, Rasaee MJ, Hossieni AZ, Tabbaraee B, Kazemnejad A.
    Roum Arch Microbiol Immunol; 2010 Apr 12; 69(1):5-12. PubMed ID: 21053778
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
    Golshani M, Rafati S, Dashti A, Gholami E, Siadat SD, Oloomi M, Jafari A, Bouzari S.
    Mol Immunol; 2015 Jun 12; 65(2):287-92. PubMed ID: 25723468
    [Abstract] [Full Text] [Related]

  • 17. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 12; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 18. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K, Yespembetov B, Matikhan N, Ryskeldinova S, Zinina N, Kydyrbayev Z, Assanzhanova N, Tabynov K, Renukaradhya GJ, Mukhitdinova G, Sansyzbay A.
    Vet Microbiol; 2016 Dec 25; 197():15-20. PubMed ID: 27938677
    [Abstract] [Full Text] [Related]

  • 19. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D, Somani VK, Aggarwal S, Bhatnagar R.
    Mol Immunol; 2015 Dec 25; 68(2 Pt A):272-9. PubMed ID: 26442664
    [Abstract] [Full Text] [Related]

  • 20. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
    Mallick AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, Chaudhuri P, Owais M.
    Vaccine; 2007 Nov 14; 25(46):7873-84. PubMed ID: 17931756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.